135 related articles for article (PubMed ID: 24172799)
1. The effects of chronic usage of enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients.
Koza Y
Anadolu Kardiyol Derg; 2013 Nov; 13(7):718. PubMed ID: 24172799
[No Abstract] [Full Text] [Related]
2. About contrast-induced nephropathy.
Yürekli I; Yazman S; Cakır H; Ozcem B
Anadolu Kardiyol Derg; 2013 Nov; 13(7):719-20. PubMed ID: 24172800
[No Abstract] [Full Text] [Related]
3. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients [corrected].
Barış N; Özpelit E; Doğan NB; Kangül H; Gül S; Akdeniz B; Güneri S
Anadolu Kardiyol Derg; 2013 May; 13(3):245-50. PubMed ID: 23261803
[TBL] [Abstract][Full Text] [Related]
4. Author's reply: To PMID 23261803.
Barış N
Anadolu Kardiyol Derg; 2013 Nov; 13(7):720. PubMed ID: 24404572
[No Abstract] [Full Text] [Related]
5. Author's reply: To PMID 23261803.
Barış N
Anadolu Kardiyol Derg; 2013 Nov; 13(7):719. PubMed ID: 24400368
[No Abstract] [Full Text] [Related]
6. Angiotensin converting enzyme inhibitors and contrast-induced nephropathy.
Toprak O
Ren Fail; 2006; 28(1):99-100. PubMed ID: 16526327
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in contrast-induced nephropathy.
Zhou L; Duan S
Kidney Blood Press Res; 2013; 38(2-3):165-71. PubMed ID: 24686005
[TBL] [Abstract][Full Text] [Related]
8. Cardiorenal disease development under chronic renin-angiotensin-aldosterone system suppression.
Sarafidis PA; Ruilope LM
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):217-9. PubMed ID: 22389391
[TBL] [Abstract][Full Text] [Related]
9. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of effect of renin-angiotensin-aldosterone system blockers on contrast-induced nephropathy.
Wang W; Qu W; Sun D; Liu X
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320919587. PubMed ID: 32370685
[TBL] [Abstract][Full Text] [Related]
11. Intensity of hydration changes the role of renin-angiotensin-aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease.
Guo XS; Wu DX; Bei WJ; Li HL; Wang K; Zhou YL; Duan CY; Chen SQ; Lian D; Li LW; Liu Y; Tan N; Chen JY
J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317708894. PubMed ID: 28490226
[TBL] [Abstract][Full Text] [Related]
12. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
13. Is angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradox.
Li X; Li T; Cong H
Cardiovasc Ther; 2012 Oct; 30(5):273-6. PubMed ID: 21884031
[TBL] [Abstract][Full Text] [Related]
14. [Drug-induced nephropathy].
Shimizu H; Tanaka A; Matsuo S
Nihon Rinsho; 2007 Oct; 65 Suppl 8():549-53. PubMed ID: 18074600
[No Abstract] [Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy after cardiac catheterization or percutaneous coronary intervention.
Patel K; King CA; Jovin IS
Cardiovasc Revasc Med; 2011; 12(2):90-3. PubMed ID: 21421186
[TBL] [Abstract][Full Text] [Related]
16. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
Beavers CJ; Dunn SP; Macaulay TE
Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
Pathak JV; Dass EE
Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
[TBL] [Abstract][Full Text] [Related]
18. Is angiotensin-converting enzyme inhibitor appropriate for contrast-induced nephropathy? A meta-analysis about this field.
Li X; Li T; Fu N; Hu Y; Cong H
Int J Cardiol; 2012 Mar; 155(3):486-8. PubMed ID: 22264872
[No Abstract] [Full Text] [Related]
19. ACE inhibitor or angiotensin II receptor blocker use is a risk factor for contrast-induced nephropathy.
Umruddin Z; Moe K; Superdock K
J Nephrol; 2012; 25(5):776-81. PubMed ID: 22322819
[TBL] [Abstract][Full Text] [Related]
20. Re: Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
Balta S; Cakar M; Demirkol S; Balta I; Kurt O
Iran J Kidney Dis; 2013 Mar; 7(2):166-7. PubMed ID: 23485545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
